1. Home
  2. KURA vs OEC Comparison

KURA vs OEC Comparison

Compare KURA & OEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • OEC
  • Stock Information
  • Founded
  • KURA 2014
  • OEC 1862
  • Country
  • KURA United States
  • OEC Luxembourg
  • Employees
  • KURA N/A
  • OEC N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • OEC Major Chemicals
  • Sector
  • KURA Health Care
  • OEC Industrials
  • Exchange
  • KURA Nasdaq
  • OEC Nasdaq
  • Market Cap
  • KURA 1.3B
  • OEC 1.5B
  • IPO Year
  • KURA N/A
  • OEC 2014
  • Fundamental
  • Price
  • KURA $15.92
  • OEC $17.71
  • Analyst Decision
  • KURA Strong Buy
  • OEC Buy
  • Analyst Count
  • KURA 7
  • OEC 3
  • Target Price
  • KURA $29.83
  • OEC $26.33
  • AVG Volume (30 Days)
  • KURA 821.5K
  • OEC 658.0K
  • Earning Date
  • KURA 11-07-2024
  • OEC 11-07-2024
  • Dividend Yield
  • KURA N/A
  • OEC 0.47%
  • EPS Growth
  • KURA N/A
  • OEC N/A
  • EPS
  • KURA N/A
  • OEC 0.54
  • Revenue
  • KURA N/A
  • OEC $1,911,500,000.00
  • Revenue This Year
  • KURA N/A
  • OEC $2.70
  • Revenue Next Year
  • KURA N/A
  • OEC $6.84
  • P/E Ratio
  • KURA N/A
  • OEC $32.81
  • Revenue Growth
  • KURA N/A
  • OEC 1.26
  • 52 Week Low
  • KURA $9.06
  • OEC $14.94
  • 52 Week High
  • KURA $24.17
  • OEC $28.48
  • Technical
  • Relative Strength Index (RSI)
  • KURA 34.68
  • OEC 59.07
  • Support Level
  • KURA $16.55
  • OEC $17.02
  • Resistance Level
  • KURA $19.73
  • OEC $18.06
  • Average True Range (ATR)
  • KURA 0.98
  • OEC 0.64
  • MACD
  • KURA -0.05
  • OEC 0.27
  • Stochastic Oscillator
  • KURA 8.86
  • OEC 88.78

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About OEC Orion S.A.

Orion SA is a manufacturer of carbon black products. Carbon black is a powdered form of carbon used to create the desired physical, electrical and optical qualities of various materials. The company's operating segments are Specialty Carbon Black and Rubber Carbon Black. It generates maximum revenue from the Rubber Carbon Black segment. Rubber Carbon Black segment is used in the reinforcement of rubber in tires and mechanical rubber goods. The Specialty Carbon Black segment is used as pigments and performance additives in coatings, polymers, printing, and special applications. Geographically, it derives a majority of its revenue from Germany.

Share on Social Networks: